Add a Thiazide-Type Diuretic
For a Black male patient with uncontrolled hypertension on amlodipine 10 mg, add a thiazide-type diuretic—specifically chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25-50 mg daily. This recommendation is based on the 2017 ACC/AHA guidelines which explicitly state that Black patients with hypertension typically require ≥2 antihypertensive medications for adequate blood pressure control, and that single-tablet combinations including either a diuretic or CCB are particularly effective in this population 1, 2.
Why a Thiazide Diuretic is the Optimal Choice
The guideline evidence is clear and consistent: in Black patients, thiazide-type diuretics are superior to RAS inhibitors (ACE inhibitors/ARBs) for both blood pressure reduction and cardiovascular event prevention when used as monotherapy or in combination regimens 2. Since your patient is already on maximum-dose amlodipine (a CCB), the logical next step is adding the other first-line agent proven most effective in Black patients.
Chlorthalidone is preferred over hydrochlorothiazide because it provides superior endpoint protection in clinical outcome trials at doses of 12.5-25 mg daily, compared to 25-50 mg daily for hydrochlorothiazide 2. Lower doses of these agents are either unproven or less effective.
Alternative: ACE Inhibitor or ARB (If Specific Comorbidities Present)
While thiazide diuretics are the primary recommendation, you should add an ACE inhibitor or ARB instead if your patient has:
- Chronic kidney disease (CKD) with proteinuria 1, 2
- Heart failure with reduced ejection fraction 1, 2
- Diabetes with nephropathy 2
In these specific scenarios, RAS blockade becomes essential despite being less effective for blood pressure control alone in Black patients. However, the guidelines note that RAS inhibitors offer no advantage over diuretics or CCBs in Black hypertensive patients with diabetes without nephropathy or heart failure 2.
Important Caveats
Be aware of increased angioedema risk: Black patients have a significantly greater risk of angioedema with ACE inhibitors compared to other populations 2. If you do prescribe an ACE inhibitor, counsel the patient about this risk and consider an ARB as a safer alternative.
Most Black patients need 2+ medications: The guidelines emphasize that most Black patients with hypertension require at least two antihypertensive agents to achieve adequate control 1, 2. Your patient being uncontrolled on amlodipine 10 mg monotherapy is the expected clinical course, not a treatment failure.
Practical Implementation
Start with:
- Chlorthalidone 12.5 mg daily, titrating to 25 mg if needed after 2-4 weeks
- OR Hydrochlorothiazide 25 mg daily, titrating to 50 mg if needed
Monitor electrolytes (potassium, sodium) and renal function 2-4 weeks after initiation, as thiazide diuretics can cause hypokalemia and hyponatremia.
If blood pressure remains uncontrolled on amlodipine plus thiazide diuretic, the next step would be adding an ACE inhibitor or ARB as triple therapy 2. Research evidence supports that triple therapy with amlodipine/valsartan/hydrochlorothiazide is effective across all demographic subgroups, including Black patients 3.